Warts Therapeutics Market Size to Outstrip $2,314.60Mn by 2028 Growth Projections at 3.4% CAGR During 2021 to 2028 COVID Impact and Global Analysis by TheInsightPartners.com

The Warts Therapeutics Market Growth impelled by rising prevalence of human papillomavirus (HPV) infections and recurrence of genital warts, and developments of new products; genital warts type to lead the market during 2021–2028.

Pune, INDIA


New York, Sept. 29, 2021 (GLOBE NEWSWIRE) -- Warts Therapeutics Market: Key Insights
According to our new research study on “Warts Therapeutics Market to 2028 – Global Analysis and Forecast – by Type, Treatment, and End User,” the Warts Therapeutics Market Size is projected to reach US$ 2,314.60 million by 2028 from US$ 1,829.54 million in 2021; it is expected to grow at a CAGR of 3.4% during 2021–2028.

Warts Therapeutics Market: Competitive Landscape and Key Developments
Bausch Health Companies Inc.; Nielsen BioSciences, Inc.; Euro Vital Pharma GmbH, Cipla Inc.; Koninklijke Utermöhlen NV; Novan, Inc.; Scholl's Wellness Company; TEVA PHARMACEUTICAL INDUSTRIES LTD; Verrica Pharmaceuticals Inc.; GlaxoSmithKline plc.; and AIM ImmunoTech Inc are among key companies operating in the warts therapeutics market. Leading players are focusing on the new product launch, expansion, and diversification of their market presence, and acquisition of new customer base for tapping the prevailing business opportunities.

Get Exclusive Sample Pages of Warts Therapeutics Market Size - COVID-19 Impact and Global Analysis with Strategic Insights at https://www.theinsightpartners.com/sample/TIPRE00024332/

In April 2021, Teva Pharmaceuticals launched the first generic version of Absorica (isotretinoin) capsules for severe recalcitrant nodular acne warts. The oral isotretinoin is a promising therapeutic choice for patients with refractory facial plane warts.

In March 21, Verrica Pharmaceuticals Inc. and Torii Pharmaceutical Co., Ltd. entered into collaboration and license agreement to develop and commercialize product candidates, including VP-102, for a topical formulation of cantharidin for the treatment of molluscum contagiosum and common warts in Japan.

In October 2019, Novan expanded its proprietary product pipeline for external genital warts by submitting request for a pre-investigational new drug (IND) application to the US Food and Drug Administration (FDA) for new product candidate—SB207.

In 2020, North America dominated the global warts therapeutics market. In addition to the rising incidence of warts and HPV infections, the rising adoption of warts therapeutics in the US and increasing research activities in these therapeutics drive the market growth in the region. The US is among largest and fastest-growing market for dermatology treatments in this region. As per the Centers for Disease Control and Prevention (CDC), ~20% of the population had sexually transmitted infections (STI), and total ~42.5 million people were infected with HPV in 2018 in the US. In addition, before HPV vaccination, ~340,000–360,000 women and men were being affected annually by genital warts caused by HPV.

Download Sample PDF Brochure of Warts Therapeutics Market Size and Growth Research Report at https://www.theinsightpartners.com/sample/TIPRE00024332/

Based on type, the warts therapeutics market is segmented into common warts, genital warts, flat warts, and others. The common warts segment is the largest shareholder in the market; however, the genital warts segment is expected to register the highest CAGR during the forecast period. By treatment, the warts therapeutics market is segmented into physical destruction, immunomodulation, and chemical destruction. The market for physical destruction is further segmented into cryotherapy, surgical removal, and laser treatment. The immunomodulation is sub segmented into interferons, retinoids, and zinc. The chemical destruction segment is further divided into bleomycin, cantharidin, salicylic acid, and others. The physical destruction segment holds the largest share of the warts therapeutics market and is anticipated to register the highest CAGR in the market during the forecast period. By end user, the warts therapeutics market is segmented into hospitals, homecare, specialty clinics, and others. The hospitals segment is the largest shareholder in the market. However, the homecare segment is estimated to register the highest CAGR in the market during the forecast period.

The rising prevalence of warts is encouraging companies in the life sciences industry to focus on research and development of new drugs for warts treatment. There is a continuous need for new, innovative therapeutic approaches for better treatment outcomes. Verrica is developing VP-102 to treat molluscum contagiosum, common warts, and external genital warts. VP-102 is currently under FDA review, and it could be the first product to treat molluscum contagiosum, a common, highly contagious skin disease that affects ~6 million people in the US. Verrica is also developing VP-103, its second cantharidin-based product candidate, for the treatment of plantar warts. Novan is developing SB206 (currently in phase III clinical trial) as a topical antiviral gel to treat viral skin infections, including external genital warts (EGW) caused by HPV.

Order a Copy of Warts Therapeutics Market Size, Share, Strategic Insights and Forecasts 2021-2028 Research Report at https://www.theinsightpartners.com/buy/TIPRE00024332/

Warts Therapeutics Market: Segmental Overview
The physical destruction segment is anticipated to register the highest CAGR in the warts therapeutics market, by treatment, during the forecast period.




Browse Related Reports:
Peptide Therapeutics Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (Generic and Innovative), Route of Administration (Parenteral, Oral, Mucosal, Pulmonary, and Others), Synthesis Technology (Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), and Hybrid Technology), and Application (Cancer, Cardiovascular Disorder, Metabolic Disorder, Respiratory Disorder, Pain, and Dermatology), and Geography

Multiple Sclerosis Therapeutics Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Drug Class (Immunosuppressant and Immunomodulators), Route of Administration (Injectable and Oral), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and E-Commerce), and Geography

Postmenopausal Vaginal Atrophy Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis by therapy type (Estrogen based drugs, Non-estrogen based drugs, others); Product types (Vaginal gels, Creams, Tablets, Rings, Patches, Others.); End User (Hospitals, Specialty clinics, Others)

Mycosis Fungoides Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Small Molecules, Biologics); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others)

Gonorrhea Therapeutics Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Infection type (Uncomplicated Gonococcal Infection, Gonococcal Arthritis, Gonococcal Meningitis and Endocarditis) ; Treatment (Monotherapy, Dual therapy) ; Route of administration (Oral, Injectable) ; Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) , and Geography

Gastrointestinal Stromal Tumors Therapeutics Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Route Of Administration (Oral, Parenteral); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography

Melanoma Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Therapy (Chemotherapy, Immunotherapy, Targeted Therapy, Radiation Therapy); Drugs (Opdivo, Yervoy, Mekinist+Tafinlar, Keytruda, Cotellic, Zelboraf, Imlygic, Generic Drugs)

Inosine Pranobex Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Type ( Tablets, Syrup ); Application ( Immunomodulation, Antiviral Applications, Others ); Application ( Immunomodulation, Antiviral Applications, Others )




About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press Release - https://www.theinsightpartners.com/pr/warts-market

Connect With Us on:
LinkedIn: https://www.linkedin.com/company/7591674/admin/
Twitter: https://twitter.com/tipmarkettrends
Facebook: https://www.facebook.com/theinsightpartners/
YouTube: https://www.youtube.com/c/TheInsightPartners
RSS/Feeds: https://www.theinsightpartners.com/feed/ | https://www.openpr.com/news/archive/139407/The-Insight-Partners.html